CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)

Status:
Completed

Trial end date:
2018-11-09

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety and pharmacodynamic of CORETOX® in the treatment of post-stroke upper limb spasticity

Phase 1

Medy-Tox